Orchestra BioMed stockholders elect directors, ratify auditor at 2025 annual meeting

Orchestra BioMed Holdings, Inc.

Class II directors Chris Cleary, Pamela Connealy, David Pacitti elected to serve until 2028.
Ernst & Young LLP ratified as independent auditor for fiscal year ending Dec. 31, 2025.
28,177,159 of 38,312,512 eligible shares represented at the June 24, 2025 annual meeting.
Each director received over 24.5 million votes for and ~3.6 million broker non-votes.
Auditor ratification passed with 28,140,709 votes for, 34,087 against, 2,363 abstentions.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.